Toca 511 and Toca FC in patients with gastrointestinal tumors in the Toca 6 study.

被引：0
|
作者：
Merchan, Jaime R.
Ostertag, Derek
Jolly, Douglas J.
Tejera, Dalissa
Gruber, Harry E.
Shorr, Jolene
机构：
[1] Univ Miami, Miami, FL USA
[2] Tocagen Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.TPS880
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS880
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF DELIVERY OF RETROVIRAL REPLICATING VECTOR, TOCA 511, IN SPONTANEOUS CANINE BRAIN TUMOR
    Robbins, Joan M.
    Dickinson, Peter J.
    York, Daniel
    Sturges, Beverly K.
    Martin, Bryan
    Higgins, Robert J.
    Bringas, John
    Bankiewicz, Krystof
    Gruber, Harry E.
    Jolly, Douglas J.
    NEURO-ONCOLOGY, 2012, 14 : 48 - 48
  • [42] COMBINATION TOCA 511 & 5-FC SIGNIFICANTLY EXTENDS SURVIVAL IN A MURINE ORTHOTOPIC MODEL OF IN rRACEREBELLAR MEDULLOBLAS TOMA
    Richardson, Angela
    Collins, Sara
    Inagaki, Akhito
    Armstrong, Valerie
    Roussel, Martine
    Robbins, David
    Ayad, Nagy
    Jolly, Douglas
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2019, 21 : 120 - 120
  • [43] Vocimagene amiretrorepvec (Toca 511) for prodrug activator gene therapy in ovarian cancer models
    Collins, S. A.
    Inagaki, A.
    Grosso, J.
    Matsuura, S.
    Kamath, P. N.
    Xu, X.
    Ince, T. A.
    Slomovitz, B.
    Kasahara, N.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 97 - 97
  • [44] Ascending dose trials of a retroviral replicating vector (Toca 511) in patients with recurrent high grade glionia
    Robbins, Joan M.
    Huang, Tiffany T.
    Jolly, Douglas J.
    Kasahara, Noriyuki
    Aghi, Manish K.
    Vogelbaum, Michael A.
    Cloughesy, Timothy F.
    Chang, Susan Marina
    Kesari, Santosh
    Mikkelsen, Tom
    Kalkanis, Steven N.
    Landolfi, Joseph C.
    Elder, J. Bradley
    Chiocca, E. Antonio
    Gruber, Harry E.
    Pertschuk, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Intravenous Toca 511 Delivery Leads to Viral DNA in Resected High Grade Glioma (HGG)
    Kalkanis, Steven N.
    Vogelbaum, Michael
    Bota, Daniela
    Ostertag, Derek
    Diego, Oscar
    Jolly, Douglas
    Skillings, Jamey
    Yagiz, Kader
    Robbins, Joan
    Chu, Alice
    Cloughesy, Timothy
    JOURNAL OF NEUROSURGERY, 2016, 124 (04) : A1153 - A1153
  • [46] Therapeutic activity of prodrug activator gene therapy with Toca 511 in experimental models of lung cancer
    Kushiya, Hiroki
    Hiraoka, Kei
    Niwa, Hiroki
    Suzuki, Tomohiro
    Inoko, Kazuho
    Inagaki, Akihito
    Sasaki, Katsunori
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Doug, Jolly J.
    Kasahara, Noriyuki
    Hirano, Satoshi
    CANCER SCIENCE, 2021, 112 : 820 - 820
  • [47] Administration of Toca 511 to Subjects with Recurrent HGG Undergoing Repeat Resection- A Ph1 Study
    Vogelbaum, Michael
    Pertschuk, Dan
    Liau, Linda
    Cloughesy, Timothy
    Kesari, Santosh
    Mikkelsen, Tom
    Landolfi, Joseph
    Elder, J.
    Chiocca, E.
    Foltz, Greg
    Chen, Clark
    Kalkanis, Steven
    Bloomfield, Stephen
    Jolly, Douglas
    Robbins, Joan
    Ostertag, Derek
    Ibanez, Carlos
    Gruber, Harry
    Pertschuk, Daniel
    JOURNAL OF NEUROSURGERY, 2015, 122 (06) : A1522 - A1523
  • [48] Toca 511 and 5-FC in Combination with Metronomic Cyclophosphamide Reduces Treg Cells and Enhances Therapy Efficacy in a Preclinical Murine Model
    Montellano, Tiffany T.
    Viaud, Sophie
    Mendoza, Daniel
    Rodriguez-Aguirre, Maria
    Gruber, Harry
    Jolly, Douglas
    Ostertag, Derek
    JOURNAL OF NEUROSURGERY, 2019, 131 (01)
  • [49] Mechanism of Action of a Retroviral Replicating Vector, TOCA 511 & 5-FC: Levels of Infection for Anti-Tumor Activity and Immunity
    Yagiz, Kader
    Hofacre, Andrew
    Lin, Amy
    Lopez-Espinoza, Fernando
    Mendoza, Daniel
    Munday, Anthony
    Mitchell, Leah
    Jolly, Douglas J.
    MOLECULAR THERAPY, 2017, 25 (05) : 58 - 59
  • [50] Therapeutic efficacy of anti-tumor immune responses activated by Toca 511/5-FC treatment in pancreatic cancer model
    Niwa, Hiroki
    Nakamura, Toru
    Kushiya, Hiroki
    Inoko, Kazuho
    Hiraoka, Kei
    Inagaki, Akihito
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Jolly, Douglas
    Kasahara, Noriyuki
    Hirano, Satoshi
    CANCER SCIENCE, 2021, 112 : 808 - 808
12345